Baymatob
PrivateLast Round
Series A
Extension
May 26, 2026
Total Funding Raised
$14.48M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Baymatob operates in Healthcare & Life Sciences and is based in Leichhardt. Its latest recorded funding round was a Series A Extension round in May 2026.
Baymatob is a medical device company developing an AI-powered maternal-fetal health platform designed to provide early warning for serious complications in pregnancy and labor.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Clinical Trials, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Baymatob Comparables
Compare Baymatob with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vasowatch | 82% | |
| VitalTrace | 81% | |
| Biorithm | 79% |
For institutional investors. Book with your work email.
Baymatob Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 26, 2026 | ||||
| Grant | May 5, 2026 | ||||
| Grant | Dec 23, 2024 | ||||
| Series A Extension | Mar 1, 2024 | ||||
| Series A | Mar 21, 2022 | ||||
Grant | Aug 21, 2019 |
For institutional investors. Book with your work email.
Baymatob Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Even Capital | Series A Extension, Series A |
| Scale Investors | Series A Extension, Series A |
| NSW Medical Device Fund | Grant |
| ANDHealth | Grant |
| Clare Ventures | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 26, 2026
$7M round with participation from Clare Ventures and Scale Investors.
- May 17, 2026
Monthly visitors grew 267% MoM, from 464 to 1.7K.
For institutional investors. Book with your work email.
Baymatob Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Baymatob's valuation, stock price, and market status.
Is Baymatob a public or private company?
Baymatob is a private company.
What is the current stock price of Baymatob?
Baymatob is a private company, so its shares have no public market price. Caplight tracks Baymatob's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Baymatob worth (valuation)?
Valuation information for Baymatob is not publicly available.
Can I buy Baymatob stock?
Baymatob shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Baymatob's last funding round?
Baymatob's most recent funding round was Series A Extension on May 26, 2026.
Who are the main investors in Baymatob?
Key investors in Baymatob include Even Capital, Scale Investors, NSW Medical Device Fund, ANDHealth, Clare Ventures.
Will Baymatob IPO soon?
No public IPO plans have been announced for Baymatob.
How can I track Baymatob secondary market activity?
Caplight tracks bids, offers, and trades in Baymatob's shares on secondary markets.